Status and Trends of HIV PANDEMIC

|

6 CME

| Over View:

|

Since its discovery in 1980, HIV has been one of the emerging viruses that presented a serious global challenge and by the end of 2015 there were approximately 36.7 million people living with HIV. In spite of the burden we have important accomplishments. By the mid-2016, 18.2 million people were already receiving antiretroviral treatment (WHO), although, tragically, there are still masses of people worldwide who do not. Antiretroviral treatment allows HIV infected people to live longer and enjoy a more fulfilling, healthier life. In addition, it has been confirmed that ART prevents onward transmission of HIV. UNAIDS, the organization of the United Nation focusing on AIDS proposes efforts to free the world from AIDS by end of 2030. Huge and trying challenges, including the emergence of drug resistance of HIV (HIVDR), or the lack of an effective vaccine, are still lying ahead. Intensive research on multiple levels focusing on the biology, epidemiology and clinical aspects of HIV and AIDS are essential for a better understanding of this “plague”. Only these efforts carry the promise that eventually we should be able to control this outbreak, and, hopefully, finally to close this chapter of infectious burdens.

 

The current course focuses on various aspects of the problem an average health care professional, even if not

directly involved in AIDS patients’ care, should be familiar with from basic sciences to diagnostic and treatment modalities, epidemiology and regulatory problems.

| Speakers:

|

Glow

|

| Learning Objectives:

  • To view the global progress in AIDS morbidity and mortality
  • To show molecular variability of the HIV and Phylogeny
  • To discuss the clinical aspects of HIV and complications
  • To make an overview on emerging diagnosis methods.
  • To discuss the clinical aspects of HIV and therapy
  • To study the effectiveness of the recent antiretrotvirus treatment
  • To discuss the clinical trials of HIV vaccinations and its effectiveness
  • To emphasis on gathering efforts for achieving global goal of ending HIV pandemic by 2030

|

| Seminar will Cover:

  • The epidemiology of HIV and its global impact
  • The molecular bases of HIV variability
  • Pathogenesis and pathophysiology
  • Methods of laboratory diagnosis
  • Clinical aspects and Therapy of AIDS
  • Opportunistic infection in AIDS patients
  • HIV vaccination and future promises
  • Health regulations related to HIV in the Gulf region

Feb 25, 2017

09:00 to 19:00

Fairmont Bab Al Bahr | Abu Dhabi

Friendly Young Doctor

Prof. Tibor Pál

Chairman

MD, PhD, DSc
Professor of Microbiology
Consultant Clinical Microbiologist

270

AED

Book Now

NAT new2 logo.png
NAT new2 logo.png
NAT new2 logo.png
NAT new2 logo.png

|

| Who Should Attend:

Infection diseases specialist, clinicians, nurses, technician, pharmacists, quality experts

|

| Agenda:

Faded Office Corridor